Form 4: IRIDEX Director William Moore Granted New Stock Options Valued at $0.94 Per Share

IRIDEX Corp. Director William M. Moore was granted new stock options for a total of 68,000 shares of common stock at an exercise price of $0.94 per share, aligning his interests with long-term company performance.

Summary

• William M. Moore, a Director of IRIDEX Corp. (IRIX), reported the acquisition of derivative securities (stock options) on June 13, 2025.
• The filing indicates the grant of two separate stock options, totaling 68,000 shares of common stock.
• The first option is for 53,000 shares, with an exercise price of $0.94 per share.
• This 53,000-share option vests upon the earlier of the one-year anniversary of the grant date (June 13, 2026) or the Company's 2026 annual meeting of stockholders.
• The second option is for 15,000 shares, also with an exercise price of $0.94 per share.
• The 15,000-share option vests monthly, with 1/48th of the total shares vesting on July 13, 2025, and each month thereafter, fully vesting on the earlier of the four-year anniversary of the grant date (June 13, 2029) or the Company's 2029 annual meeting of stockholders.
• Both options were granted pursuant to the Company's 2008 Equity Incentive Plan, as amended, and are exempt under Rule 16b-3.
• Both options have an expiration date of June 13, 2032.

Sentiment

Score: 6

Explanation: The sentiment is slightly positive as the grant of stock options to a director aligns their interests with shareholders, which is generally viewed favorably, though it is a routine compensation event.

Positives

• The grant of stock options to a director aligns management's interests with those of shareholders, incentivizing long-term company performance and value creation.
• The options were granted under an existing, approved equity incentive plan, indicating a structured approach to executive compensation.

Future Outlook

The vesting schedules for the granted options extend through 2026 and 2029, indicating a long-term incentive structure for the director. The options expire in 2032, providing a long window for potential exercise.

Industry Context

This Form 4 filing is a routine disclosure of an insider's equity transaction, specifically the grant of stock options as part of executive compensation. Such grants are common practice across various industries to align the interests of directors and executives with those of shareholders.

Related Party Transactions

• The grant of stock options to William M. Moore, a Director of IRIDEX Corp., constitutes a related party transaction as it involves an equity award from the company to an insider.

Stakeholder Impact

• Shareholders: The grant of options aims to align the director's financial interests with long-term shareholder value creation, potentially leading to improved company performance.
• Employees: While not directly impacted by this specific filing, the company's equity incentive plan provides a framework for employee compensation and retention.

Next Steps

• The options will vest according to their respective schedules, with the earliest vesting for the 53,000 share option occurring on June 13, 2026, or the 2026 annual meeting.
• The 15,000 share option will begin monthly vesting on July 13, 2025, and continue until fully vested by June 13, 2029, or the 2029 annual meeting.
• The director may choose to exercise these options at any time after vesting and before their expiration date of June 13, 2032.

Key Dates

Keywords

IRIDEX Corp, IRIX, SEC Form 4, Stock Options, Insider Transaction, Director Compensation, Equity Incentive Plan, Beneficial Ownership, Derivative Securities